Virology

    Cards (42)

    • What are pathogens?
      infectious agents that cause disease in their hosts 
    • Consequences of viruses?
      epidemics 
    • Friedrich Loeffler + Paul Frosch & modern concept of a virus :  
      • Discovered first animal virus (foot and mouth disease) 
      • Closest to the modern concept of a virus: 
      • Filterable particle too small to be observed in light microscope but able to cause disease by multiplying in living cells 
       
    • Development of tissue culture cell lines : 
      • Used to grow viruses in lab by infecting them with viruses 
      • Viewed under light microscope  
      • Led to advancements in research 
       
    • What are different types of virology research (current)? : 
      • Virus diversity : - shape + size (more diverse than bacteria, plants + animals combined)
      • Virus epidemiology  
      • Viral pathogenesis 
      • Viral replication/interaction with host cells 
      • Viral particle structure 
      • Anti-viral 
      • Vaccines 
      • Gene therapy 
    • What are viruses?
      • infectious, obligate intracellular parasites comprising genetic material surrounded by a protein coat

      • uses host cell machinery to replicate viral genome + produce viral proteins
      • assembles from proteins + genomes formed in infected cells
      • DON'T REPLICATE BY DIVISION
    • Where do viruses exist?
      1. Outside host cells = inactive, possess few enzymes + can't reproduce outside living cells
      2. Inside host cells = as nucleic acids which transform host cells into virus factories
    • Virus particles
      • viral genome surrounded by a capsid
      • capsid = protein coat (produces genetic material + aids transfer to host cells)
      • some capsids are surrounded by an envelope (lipid bilayer derived from host)
      • nucleocapsid = capsid + viral nucleic acid
      • virion = complete infectious virus particle
    • Capsid structure
      • self assembles from multiple copies of structural proteins
      • individual protein subunit of a capsid = promoter
      • can be helical, icosahedral or complex
    • Helical capsid
      • hollow tubes w/ protein walls
      • rigid/flexible
      • size of capsids = function of nucleic acids
      • helical array of promoters
      • viral nucleic acid spirals on the inside
    • Icosahedral capsid
      • 20 triangular faces arranged around the surface of a sphere
      • most efficient way to enclose a space
      • assembles from pentamers or hexamer
      • assembled virus capsid = 12 pentamers
    • Viral envelopes
      • lipo-protein bilayer derived from host
      • obtained when virus particles 'bud' through host cell membranes (plasma, or sometimes golgi/nuclear)
      • virus proteins embedded (spikes) : viral attachment to host antigenic site via spike proteins on virus surface + receptor on host cell surface
    • Virion enzymes
      • variety of virions have enzymes
      • mostly within capsid
      • involved in nucleic acid replication
      • e.g. retrovirus (HIV) , reverse transcriptase (converts viral RNA into DNA), intergrase (integrates viral DNA into host genome)
    • Central dogma of molecular biology (Francis Crick)
      • describes flow of genetic info in cells
      • (1) genetic info stored in the form of DNA
      • (2) DNA replicates
      • (3) DNA transcribed into RNA
      • (4) RNA translated into proteins via ribosome
      • not all viruses follow this as some are made of RNA and not DNA
    • Viral genome
      • DNA or RNA
      • ss or ds
      • ss: '+' or '-' sense
      • virus mRNA = '+'
      • if viral genome of DNA/RNA is complementary to genome of mRNA = '+' , then reverse of mRNA genome = '-'
      • linear or circular
      • continuous or segmented
    • Viral replication cycle
      • mechanisms depend on virion structure + genome
      • (1) attachment to host cell via specific receptors
      • (2) entry into host cell
      • (3) uncoating
      • (4) synthesis of viral nucleic acids + proteins
      • (5) self-assembly of nucleocaspids
      • (6) release from host cell
    • non-enveloped virus replication cycle
      1. attachment via specific receptors
      2. entry via endocytosis
      3. uncoating
      4. macromolecular synthesis: synthesis of viral proteins and replication of viral genome
      5. assembly of viral particle (viral genome + proteins)
      6. release by lysis
    • enveloped virus replication cycle
      1. attachment via specific receptors
      2. entry via endocytosis/membrane-fusion
      3. uncoating
      4. macromolecular synthesis: synthesis of viral proteins and replication of viral genome
      5. assembly of viral particles (viral genome + proteins)
      6. release by budding
    • What does virus genome dictate?
      how a viral mRNA is synthesised and how the viral genome is replicated
    • Baltimore classification - simplifies viral life cycles into 7 basic types, based on:
      • DNA or RNA
      • ds or ss (+ or -)
      • RT or not
      • (1) DNA viruses : ds DNA or ss DNA
      • (2) RNA viruses : ds RNA or ss RNA (+) or ss RNA (-)
      • (3) retro-transcribing viruses : ds DNA (RT) , ss RNA (RT)
      • every viral genome needs to be converted into mRNA to enable translation into proteins by host ribosomes
    • Baltimore classification (2)
      • ds DNA = majority of DNA viruses
      • ss DNA = converted into ds
      • ds, ss (+), ss (-) RNA all require viral RdRP
      • ss (+) RNA = genome can be directly translated upon entry
      • ss (-) RNA = needs to be converted into + while bringing RdRp into infected cell
      • retroviruses (ds DNA + ss RNA) = bring RT + integrase into infected cell. ds DNA integrates into host cell genome
    • Viral classification taxonomy
      • goal = categorise viruses into single classification scheme, reflecting their evolutionary relationships
      • ICTV = international committee on taxonomy of viruses, responsible for classification into taxa + naming taxa
      • 15 taxonomical hierarchical ranks
      • most used = family, genus, species
    • Techniques used to measure number of infectious viral particles?
      1. plaque assay
      2. end-point dilution assay (TCID50)
    • Plaque assay
      • determines the virus tirte (conc. of infectious viral particles) in a sample
      • 1, prepare serial dilutions of virus - containing sample
      • 2, inoculation of susceptible cells in culture
      • 3, after virus attaches, cover cells with agar to restrict diffusion
      • 4, original infected cells release viral progeny, spreading to neighbouring cells
      • 5, each infectious viral particle produces a plaque (circular zone of infected cells
      • 6, virus titre of original sample calculated as plaque-forming units (PFU)/ml
    • End-point dilution assay (TCID50)
      • determines dilution of a virus required to infect 50% of inoculated cell cultures
      • 1, prepare serial dilutions of virus - containing sample
      • 2, inoculation of susceptible cells in culture
      • 3, incubate
      • 4, observe w/ light microscope , score CPE (cytopathic effect), CPE present (circular) = virus present and if CPE absent (sausage) = no virus
      • 5, virus of titre of original sample = TCID50 units/ml
      • end-point = dilution where 50% of cells are infected or display CPE
    • Techniques used to measure number of viral particles:
      1. Electron microscopy : see viral particles + count them
      2. ELISA (enzyme-linked immunosorbent assay) : quantify viral proteins
      3. qPCR - quantify viral genome
    • One step growth cycle
      • studies viral replication cycle
      • used to analyse virus + host factors that facilitate viral replication
      • 1, short exposure to high number of virions
      • 2, wash away virions that don't attach to cells
      • most cells infect at the same time
      • synchronous viral replication in most of the cells
      3 phases : eclipse, burst, plateau
    • Routes of viral entry to humans:
      1. conjuctiva
      2. respiratory tract
      3. gastro-intestinal tract
      4. urogenital tract
      5. skin
      6. placenta
    • Viral pathogenesis (1) : DISEASE
      • due to virus causing:
      • cell destruction
      • cellular dysfunction
      • immunosuppression
    • Viral pathogenesis (2) : INFECTION
      • acute virus infection can be:
      • clearance : recovery
      • fatal : death
      • persistent : death or latent
      • can lead to:
      • cell/tissue tropism
      • subversion of host molecules/mechanisms
      • evasion from host responses
      • mutation
      • host can gain:
      • susceptibility, immunity, genetic variations in specific genes
    • Tissue tropism: spectrum of tissues infected by a virus
      • ranges from limited to pantrophic (affects many types of cells)
      • determined by:
      • susceptibility, permissivity, accessibility + defense
    • Effect of viral infection on cells
      • cell death : most enveloped viruses
      • cell dysfunction (cell transformation)
      • no effect
      • some viruses induce an alteration of host cell functions (pathological consequences)
      • transformation of host cells by viruses can lead to oncogenesis (cancer)
    • Immune response to viral infections
      • host defences:
      • physical barriers: skin, mucus, saliva, stomach acid, tears
      • intrinsic : autophagy, apoptosis
      • innate : killer T-cells, dendritic cells, cytokines, complement
      • adaptive: T-lymphocytes, B-lymphocytes, antibodies
    • Intrinsic + innate responses to viruses, Virus detection = immediate + not antigen specific
      • indirect: alteration of normal cellular processes
      • apoptosis = programmed cell death (blocks virus replication)
      • tissue - resident sentinel cell takes up apoptotic bodies
      • autophagy = membrane encloses virus + fuse w lysosome to degrade viral particles (phagophore -> autophagosome -> lysosome -> degradation)
    • Intrinsic + innate responses, direct virus detection
      • PRRs (pattern recognition receptors)
      • 1, recognise viral nucleic acids + proteins
      • 2, signalling cascade
      • 3, activation of transcription factors IRF3/7 + NF/KB
      • 4, gene expression of:
      • inflammatory cytokines: soluble proteins that AFFECT OTHER CELLS BEHAVIOUR, secreted -> inflammation -> recruitment/activation of immune cells = (DCs instruct adaptive immunity + NK cells kill infected cells)
      • Type 1 IFN : cytokines that ACTIVATES ANTIVIRAL PROGRAMMES, secreted -> binds IFN receptor -> signalling cascade -> ISGs expression -> antiviral effect
    • Intrinsic + innate responses, sentinel cells
      • dendritic cells (DCs), macrophages, natural killer cells (NK)
      • patrol tissues looking for signs of change
    • Main mechanisms to prevent viral evasion:
      1. neutralising antibodies = adaptive immune response that provides long-lasting protection by blocking viral entry + promoting clearance
      2. cytotoxic T-lymphocytes = adaptive immune response that provides long-lasting protection by killing infected cells
      3. cell intrinsic = induced by type 1 IFNs that inhibit viral replication
      4. cytotoxic NK cells = directly kill infected cells
    • Difference between innate + adaptive immune response
      • innate = not antigen-specific
      • adaptive = antigen-specific and long-lasting
    • What happens when you don't clear viral infections?
      • IFN (inflammatory response)
      • needs to be controlled
      • Locally : many ISGs (interferon-stimulated gene) inhibit viral replication but damaging to tissuestoxic for cells 
      • In circulation: too much ISGs secreted locally -> enter bloodstream -> trigger flu-like symptoms (fever, chills, nausea, malaise
      • There are regulators of IFN signaling / inflammatory cytokines to avoid pathology once viral replication is controlled 
    • Immunopathology
      • due to: 
      • Uncontrolled innate immune response (IFN/Inflammatory cytokines)  
      • Damaging effects of adaptive immune response 
      •  symptoms of viral disease (fever, tissue damage, aches, pains, nausea)  
      • mainly a consequence of host response to infection.